Michael Olin, PhD

Assistant Professor, Department of Pediatrics

Michael Olin

Contact Info

olin0012@umn.edu

Office Phone 612-626-2778

Fax 612-626-2815

Office Address:
Masonic Cancer Center
MMC 806
420 Delaware St SE
Minneapolis, MN 55455

Mailing Address:
Pediatric Hematology-Oncology
MMC 484
420 Deleware ST. SE
Minneapolis, MN 55455

Administrative Assistant Name
Lynn Levercom Wodziak

Administrative Phone
612-626-2602

Administrative Email
lleverco@umn.edu

Postdoctoral Fellowship, University of Minnesota Medical School, Minneapolis, MN

PhD, Infectious Disease, University of Minnesota, Minneapolis, MN

BA & BS, Chemistry, Hydrogeology, Biochemistry, University of Minnesota, Minneapolis, MN

Summary

Dr. Olin is an Assistant Professor in the Department of Pediatrics, Division of Hematology/Oncology. Dr. Olin graduated from the University of Minnesota, Duluth, in 1995 with a BS in biochemistry and a BA in chemistry. After graduating, he worked in industry for 5 years before returning to the U of M to complete his PhD in Veterinary Medicine (Infectious Disease) in 2005. From 2006-2008 Dr. Olin did a postdoctoral fellowship with Dr. Philip Peterson studying the effects of opioids on tuberculosis meningitis, and from 2008-2011 he did a second post doctoral fellowship with Dr. John Ohlfest in brain tumor immunotherapy. Dr. Olin joined the Department of Pediatrics Faculty as an Assistant Professor in 2011.

Awards & Recognition

  • Co-chair Alumni Research Network Program, American Brain Tumor Association (2014)
  • Elected into the American Brain Tumor Alumni Research Network Program (2013)
  • Young Investigators Award, PharmacoNeuroImmunology Research Society (2002)
  • Young Investigators Award, Society of NeuroImmune Interaction and Pharmacology (2001)

Research

Research Summary/Interests

Dr. Olin’s scientific interest is defining the mechanism(s) of suppression inhibiting the ability to mount a tumoricidal response evident in the tumor draining lymph nodes and tumor environment and developed potential ways to modulate the immunosuppressive activity. Immunosuppressive tumor environment is a major hurdle for the immune system to overcome. Dr. Olin is focused on the development of inhibitors derived to overcome the suppressive tumor microenvironment.